We've found
954
archived clinical trials in
Fibromyalgia
We've found
954
archived clinical trials in
Fibromyalgia
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
D-Ribose for Fatigue in Subjects With Fibromyalgia
Updated: 6/28/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Click here to add this to my saved trials
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Updated: 8/14/2012
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated: 8/14/2012
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Updated: 8/14/2012
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated: 8/14/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Updated: 8/23/2012
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
Updated: 10/22/2012
Urocortins and Musculoskeletal Hyperalgesia
Status: Enrolling
Updated: 10/22/2012
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
Updated: 10/22/2012
Urocortins and Musculoskeletal Hyperalgesia
Status: Enrolling
Updated: 10/22/2012
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
A Study of IMC-1 In Patients With Fibromyalgia
Updated: 5/11/2013
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
Click here to add this to my saved trials
Effect of Milnacipran on Pain in Fibromyalgia
Updated: 6/24/2013
Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study
Status: Enrolling
Updated: 6/24/2013
Effect of Milnacipran on Pain in Fibromyalgia
Updated: 6/24/2013
Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study
Status: Enrolling
Updated: 6/24/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials